Hangzhou Tigermed Consulting (300347) — Net Asset Quality Index
Hangzhou Tigermed Consulting (300347) has a Net Asset Quality Index of 85.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥28.80 Billion minus total liabilities of CN¥4.24 Billion yields net assets of CN¥24.56 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Hangzhou Tigermed Consulting for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hangzhou Tigermed Consulting Net Asset Quality Index Over Time (2009–2025)
This chart shows how Hangzhou Tigermed Consulting's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the index stands at 85.3%, representing net assets of CN¥24.56 Billion against total assets of CN¥28.80 Billion CNY. For live market cap and overall valuation, see 300347 market cap.
Annual Net Asset Quality Index for Hangzhou Tigermed Consulting (2009–2025)
The table below presents the year-by-year Net Asset Quality Index for Hangzhou Tigermed Consulting from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Hangzhou Tigermed Consulting (300347) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.5% | CN¥24.26 Billion | CN¥28.36 Billion | CN¥4.10 Billion | ▲ +1.6 pp |
| 2024 | 83.9% | CN¥24.06 Billion | CN¥28.67 Billion | CN¥4.61 Billion | ▲ +1.5 pp |
| 2023 | 82.4% | CN¥24.45 Billion | CN¥29.68 Billion | CN¥5.23 Billion | ▼ -0.2 pp |
| 2022 | 82.6% | CN¥22.68 Billion | CN¥27.45 Billion | CN¥4.77 Billion | ▼ -4.2 pp |
| 2021 | 86.8% | CN¥20.61 Billion | CN¥23.74 Billion | CN¥3.14 Billion | ▼ -4.8 pp |
| 2020 | 91.6% | CN¥17.86 Billion | CN¥19.51 Billion | CN¥1.65 Billion | ▲ +18.6 pp |
| 2019 | 73.0% | CN¥5.52 Billion | CN¥7.57 Billion | CN¥2.05 Billion | ▲ +3.0 pp |
| 2018 | 69.9% | CN¥3.27 Billion | CN¥4.68 Billion | CN¥1.41 Billion | ▼ -8.2 pp |
| 2017 | 78.2% | CN¥2.80 Billion | CN¥3.58 Billion | CN¥781.85 Million | ▲ +1.1 pp |
| 2016 | 77.0% | CN¥1.84 Billion | CN¥2.39 Billion | CN¥548.54 Million | ▲ +10.8 pp |
| 2015 | 66.2% | CN¥1.07 Billion | CN¥1.61 Billion | CN¥544.12 Million | ▼ -1.3 pp |
| 2014 | 67.5% | CN¥916.90 Million | CN¥1.36 Billion | CN¥440.72 Million | ▼ -25.9 pp |
| 2013 | 93.5% | CN¥755.14 Million | CN¥808.01 Million | CN¥52.87 Million | ▼ -1.3 pp |
| 2012 | 94.7% | CN¥694.32 Million | CN¥732.84 Million | CN¥38.52 Million | ▲ +16.6 pp |
| 2011 | 78.2% | CN¥146.03 Million | CN¥186.76 Million | CN¥40.73 Million | ▼ -1.7 pp |
| 2010 | 79.9% | CN¥95.79 Million | CN¥119.91 Million | CN¥24.12 Million | ▲ +14.2 pp |
| 2009 | 65.7% | CN¥44.26 Million | CN¥67.39 Million | CN¥23.13 Million | — |